Table 1.
characteristics of patients included in the study
| Variable | Total (N = 40) | Male (n = 26) | Female (n = 14) | p-valuea | |||
|---|---|---|---|---|---|---|---|
| Mean± SD | Median (Q1; Q3) | Mean±SD | Median (Q1; Q3) | Mean ±SD | Median (Q1; Q3) | ||
| Age (years) | 53.0 (42.8; 60,2) | 53.0 (42.2; 60.0) | 51.5 (46.0; 63.0) | 1.000 | |||
| Hemoglobin (g/dL) | 10.7 ±2.7 | 11.0 ±3.2 | 10.1±1.3 | 0.222 | |||
| Leukocytes (×103/µL) | 14.9 (9.0; 21.2) | 12.8 (8.2; 21.3) | 16.9 (13.3; 21.0) | 0.192 | |||
| Erythrocytes (×106/µL) | 3.8 ±1.0 | 3.9 ±1.1 | 3.7 ±0.6 | 0.480 | |||
| Hematocryte (%) | 31.4 ±7.8 | 32.2 ±9.1 | 29.9 ±4.3 | 0.282 | |||
| Platelets (×10 3/µL) | 269.0 (215.5; 450.5) | 262.0 (214.5; 446.2) | 372.0 (268.2; 439.2) | 0.173 | |||
| Eosinofil (%) | 0.0 (0.0; 2.0) | 0.0 (0.0; 2.2) | 1.0 (0.0; 2.0) | 0.680 | |||
| Rod Neutrophils (%) | 2.5 (0.0; 9.0) | 2.0 (0.0; 13.0) | 3.0 (1.0; 4.5) | 0.574 | |||
| Segmented Neutrophils (%) | 70.0 (61.0; 78.0) | 67.5 (56.8; 76.5) | 71.0 (67.0; 80.0) | 0.161 | |||
| Lymphocytes (%) | 16.9 ±7.9 | 17.0 ±8.1 | 16.5 ±7.7 | 0.856 | |||
| Monocytes (%) | 6.0 (4.0; 9.0) | 6.0 (4.0; 8.2) | 6.0 (4.0; 9.0) | 0.872 | |||
| NLR | 4.0 (2.6; 5.8) | 4.4 (2.4; 5.6) | 3.5 (3.2; 7.7) | 0.656 | |||
| Sodium (mg/dL) | 133.9 ±8.0 | 134.7 ±8.7 | 132.8 ±6.9 | 0.504 | |||
| Potassium (mg/dL) | 4.2 (3.5; 4.7) | 4.2 (4.0; 4.8) | 4.2 (3.4; 4.6) | 0.478 | |||
| Chloride (mg/dL) | 96.2 ±8.9 | 98.1 ±8.3 | 93.4 ±9.4 | 0.141 | |||
| SGOT (mg/dL) | 27.5 (18.2; 46.2) | 23.0 (17.0; 47.0) | 35.0 (23.0; 44.0) | 0.435 | |||
| SGPT (mg/dL) | 19.0 (13.0; 25.2) | 19.0 (14.0; 36.0) | 18.0 (13.0; 20.0 | 0.279 | |||
| Urea (mg/dL) | 38.0 (24.0; 97.0) | 38.5 (24.2; 82.2) | 31.0 (24.0; 149.0) | 0,864 | |||
| Creatinine (mg/dL) | 1.1 (0.7; 2.0) | 1.1 (0.8; 2.0) | 0.9 (0.6; 1.7) | 0.214 | |||
| COVID-19, n (%) | |||||||
| Not tested | 6 (15) | 5 (19) | 1 (7) | 0.723 | |||
| Negative | 24 (60) | 15 (58) | 9 (64) | ||||
| Positive | 10 (25) | 6 (23) | 4 (29) | ||||
| ICAM-1 serum Level (ng/mL) | |||||||
| Initial | 265.4 (182.1; 315.0) | 265.4 (193.6; 314.1) | 264.0 (155.0; 315.0) | 0.769 | |||
| Continued | 236.3 (169.3; 308.4) | 229.2 (180.6; 304.6) | 262.3 (141.3; 310.9) | 0.967 | |||
| Changed | -0.7 (-8.6; 13.6) | 0.5 (-7.7; 18.9) | -2.6 (-15.9; 4.3) | 0.361 | |||
a
t-test or Mann-Whitney U test on numeric variables, 2 tests (or Fisher's Exact) on categorical variables; SD, standard deviation; Q1, Quartile 1; Q3, Quartile 3; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamate-pyruvate transaminase; NLR, Neutrophil Lymphocyte Ratio